Table 4. The association of CEA and CA125 with AE.
Variables | Categorical | Continuous | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 1 | Model 2 | ||||||||
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | ||||
CEA | 2.66 (1.51–4.69) | 0.001 | 2.00 (1.12–3.59) | 0.02 | 2.10 (1.49–2.95) | <0.001 | 1.77 (1.22–2.56) | 0.003 | |||
CA125 | 2.12 (1.23–3.64) | 0.007 | 1.44 (0.79–2.65) | 0.24 | 1.50 (1.12–1.99) | 0.006 | 1.24 (0.89–1.72) | 0.21 |
Model 1: crude; Model 2: adjusted for DLCO% pred., age, pulmonary hypertension, honeycombing, emphysema. AE, acute exacerbation; CA125, carbohydrate antigen 125; CEA, carcinoembryonic antigen; CI, confidence interval; HR, hazard ratio; DLCO% pred., percent predicted for diffusion capacity of the lung for carbon monoxide.